sb 216763 has been researched along with Leukemia, Myeloid, Acute in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cleary, ML; Ficara, F; Iwasaki, M; Lin, C; Matheny, C; Smith, KS; Wang, Z; Wong, SH | 1 |
1 other study(ies) available for sb 216763 and Leukemia, Myeloid, Acute
Article | Year |
---|---|
GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; CREB-Binding Protein; Cyclic AMP Response Element-Binding Protein; DNA-Binding Proteins; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Glycogen Synthase Kinase 3; Homeodomain Proteins; Humans; Indoles; Leukemia, Myeloid, Acute; Maleimides; Mice; Mice, Inbred C57BL; Models, Biological; Myeloid Ecotropic Viral Integration Site 1 Protein; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Phosphorylation; Pre-B-Cell Leukemia Transcription Factor 1; Protein Binding; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Signal Transduction; Transcription Factors; Transcription, Genetic | 2010 |